Genovese, Mark C.
Stanford University
8 papers on CoChatORCID 0000-0001-5294-4503
Most cited papers
- Verified
Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study
Genovese, M. C., McKay, J. D., Nasonov, E. L., Mysler, E. F., da Silva, N. A., Alecock, E., Woodworth, T., & Gomez‐Reino, J. J. (2008) · Arthritis & Rheumatism
Rheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders Research
Cited by 855
- Verified
Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study
Jones, G., Sebba, A., Gu, J., Lowenstein, M. B., Calvo, A., Gomez-Reino, J. J., Siri, D. A., Tomšič, M., Alecock, E., Woodworth, T., et al. (2010) · Annals of the Rheumatic Diseases
Rheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders Research
Cited by 797
- Verified
CCR7 Expression and Memory T Cell Diversity in Humans
Campbell, J. J., Murphy, K. E., Kunkel, E. J., Brightling, C. E., Soler, D., Shen, Z., Boisvert, J., Greenberg, H. B., Vierra, M. A., Goodman, S. B., et al. (2001) · The Journal of Immunology
Chemokine receptors and signalingT-cell and B-cell Immunology
Cited by 335
- Verified
A phase II randomized study of subcutaneous ixekizumab, an anti-interleukin-17 monoclonal antibody, in rheumatoid arthritis patients who were naive to biologic agents or had an inadequate response to tumor necrosis factor inhibitors
Genovese, M. C., Greenwald, M., Cho, C., Berman, A., Jin, L., Cameron, G. S., Benichou, O., Xie, L., Braun, D., Berclaz, P., et al. (2014) · Arthritis & Rheumatology
Rheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders Research
Cited by 211
- Verified
Subcutaneous abatacept versus intravenous abatacept: A phase IIIb noninferiority study in patients with an inadequate response to methotrexate
Genovese, M. C., Covarrubias, A., Leon, G., Mysler, E., Keiserman, M., Valente, R., Nash, P., Simon‐Campos, J. A., Porawska, W., Box, J., et al. (2011) · Arthritis & Rheumatism
Rheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders Research
Cited by 196
- Verified
A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus.
van Vollenhoven, R. F., Park, J. L., Genovese, M. C., West, J. P., & McGuire, J. L. (1999) · Lupus
Systemic Lupus Erythematosus ResearchAdrenal Hormones and Disorders
Cited by 144
- Verified
Gene expression changes reflect clinical response in a placebo-controlled randomized trial of abatacept in patients with diffuse cutaneous systemic sclerosis
Chakravarty, E. F., Martyanov, V., Fiorentino, D., Wood, T. A., Haddon, D. J., Jarrell, J. A., Utz, P. J., Genovese, M. C., Whitfield, M. L., & Chung, L. (2015) · Arthritis Research & Therapy
Systemic Sclerosis and Related DiseasesDupuytren's Contracture and Treatments
Cited by 117
- Verified
Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept
Alten, R., Bingham, C. O., Cohen, S. B., Curtis, J. R., Kelly, S., Wong, D., & Genovese, M. C. (2016) · BMC Musculoskeletal Disorders
Rheumatoid Arthritis Research and TherapiesPneumonia and Respiratory Infections
Cited by 75
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free